product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
Mouse anti Bovine CD205
catalog :
MCA1651GA
quantity :
0.1 mg
price :
288 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
CC98
reactivity :
human, domestic sheep
application :
immunoprecipitation, flow cytometry, immunohistochemistry - frozen section
more info or order :
citations: 1
Published Application/Species/Sample/DilutionReference
  • immunohistochemistry - frozen section; domestic sheep
Piercey Åkesson C, Press C, Tranulis M, Jeffrey M, Aleksandersen M, Landsverk T, et al. Phenotypic characterization of cells participating in transport of prion protein aggregates across the intestinal mucosa of sheep. Prion. 2012;6:261-75 pubmed publisher
image
image 1 :
Bio-Rad MCA1651GA image 1
Published customer image: . Mouse anti Bovine CD205 antibody, clone CC98 ( MCA1651GA ) used to evaluate CD205 expression on ovine lymph derived dendritic cells by flow cytometry. Image caption: . CD1b+ L-DCs are migratory mature DC capable of endocytic and phagocytic activities. After labelling lymph cells with anti- CD1b mAb (A), CD1b+ L-cells were gated and analysed for the expression of different markers. Data express the median (quartiles) of the percentage of positive cells from 3 sheep (B). Plots of different markers expressed by CD1b+ L-DCs are shown (C). May-Gr nwald Giemsa staining of sorted and cytocentrifugated CD1b+ L-DCs (D). Expression of mRNA for CCR7, CD103 and DC-SIGN by sorted CD1b+ L-DCs (1, 3, 5 respectively) and in cDNA control (2, 4, 6 respectively) (E). Uptake of FITC-ovalbumin (FITC-OVA) or GFP- Salmonella by CD1b+ L- DCs. Lymph cells (1×10 6 cells) were incubated with FITC-OVA for 1h at 4 C or 37 C, or with GFP- Salmonella for 30 min at 37 C, followed by CD1b labelling. CD1b+ L- DC subset was gated on lymph cells and FITC-OVA fluorescence shown on dot plots F and G. Total L-APC were gated on SSC/FSC and the cell population negative for lymphocyte markers. Quadrants were then defined on the CD1b+ and CD1b- subsets and GFP- Salmonella fluorescence shown on dot plot H. From: Olivier M, Foret B, Le Vern Y, Guilloteau LA (2012). Capacities of Migrating CD1b+ Lymph Dendritic Cells to Present Salmonella Antigens to Naive T Cells. PLoS ONE 7(1): e30430 .
product information
Entity Type :
Monoclonal Antibody
Entity Category :
Antibodies
ProductCode :
MCA1651GA
Description :
Mouse anti Bovine CD205
Specificity :
CD205
TargetSpecies :
Bovine
Host :
Mouse
Format :
Purified
Isotypes :
IgG2b
Applications :
IP,F,C
ApplicationTypes :
Immunoprecipitation,Flow Cytometry,Immunohistology - Frozen
Cross Reactivities :
Sheep
Clone :
CC98
Quantity :
0.1 mg
Quantity Value :
0.1
Quantity Type :
mg
Published Synonyms :
DEC-205,WC6 Antigen
Entity Formats :
FITC,Purified
UNSPSC :
41116161
Concentration :
IgG concentration 1.0 mg/ml
Product Form :
Purified IgG - liquid
PriceGBP :
206
PriceEUR :
288
PriceUSD :
288 USD
PriceCHF :
313
PriceSEK :
3283
PriceNOK :
3278
PriceDKK :
2148
more info or order :
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.